Sentiment Summary
Recent Events
Ex-dividend date (2026-06-08) for a quarterly cash dividend of $0.22 per share, representing a 5% increase from the prior dividend. The dividend was declared on April 27, 2026 and is payable on June 15, 2026. A 1-2% price impact is estimated as dividend increases are generally viewed positively by the market, scheduled.
Ex-dividend date on 2026-06-05 for the proposed final dividend of HKD 1.206 per share for the 2025 fiscal year. This standard corporate action is estimated to have a >1% price impact, scheduled.
Q2 2026 earnings release scheduled. Medium importance justified by anticipation of key financial performance data.
Ex-dividend date for the 2025 final dividend of RMB 2.2 per 10 shares on June 3, 2026. Payment is scheduled for June 26, 2026, scheduled.
Annual General Meeting for 2026-05-29 scheduled.
Kuaishou Technology is expected to announce its first quarter 2026 financial results on May 27, 2026. Analysts forecast revenue and adjusted profit to be in line with market consensus, and the event is expected to cause over 10% price volatility expected.
Xiaomi is scheduled to release its Q1 2026 financial results on May 27, 2026; high importance is estimated due to the historical impact of quarterly earnings on stock price volatility, scheduled
Annual General Meeting (AGM) and Extraordinary General Meeting (EGM) on 2026-05-27 to approve the final dividend and a new share award scheme. Governance updates are estimated to have a >1% price impact, scheduled.
Salesforce is scheduled to release its first-quarter fiscal 2027 financial results on 2026-05-27 after the market close. This scheduled release is estimated to have at least a 1% price impact scheduled.
Ex-dividend date on May 26, 2026 for a proposed final dividend of HK$0.35 per share for fiscal year 2025, a 45.8% increase from the prior year scheduled.
Q4 and full-year results for the fiscal year ending March 31, 2026, are scheduled to be announced. A final dividend will also be considered. This is a future event, so importance is an estimate based on typical market reaction to annual earnings reports. scheduled
Quarterly dividend ex-date of $0.91 per share on 2026-05-21. The dividend was declared on March 10, 2026, and is payable on June 11, 2026.
Analog Devices is scheduled to release its second quarter fiscal year 2026 financial results on May 20, 2026; high importance is estimated due to historical earnings volatility, scheduled.
NVIDIA is scheduled to announce its financial results for the first quarter of fiscal year 2027, which ended on April 26, 2026. A conference call will be held on the same day. Market impact is estimated as Neutral until the actual financial data is released, scheduled.
The company will hold an online investor briefing on May 20, 2026, to discuss its first-quarter 2026 financial and operating results, scheduled. This event is estimated to have a price impact of at least 1%.
Company executives participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 20, 2026; low impact estimated as conferences typically provide incremental updates scheduled
An Investor Day is scheduled to be held in New York City on 2026-05-20 scheduled. This event is estimated to have a low impact as it is a routine update for investors.
Palo Alto Networks is scheduled to announce its Q3 2026 earnings results on 2026-05-19. Analysts forecast EPS of around $0.79-$0.81 forecasted. Neutral impact is estimated as the market awaits actual performance against these estimates.
Q1 2026 earnings results and conference call on May 15, 2026, with a 1-5% price impact estimated as quarterly results typically drive moderate volatility, scheduled.
First quarter 2026 earnings release on May 14, 2026; medium impact estimated as a key quarterly performance update expected.
Fiscal Q2 2026 earnings results and conference call on May 14, 2026, scheduled; estimated to have a medium impact of ≥5%.
Ex-dividend date for the final dividend of HK$1.32 per share for the year ended December 31, 2025, on May 14, 2026, scheduled. Low impact expected as it is a routine ex-dividend date.
Tencent is scheduled to announce its Q1 2026 financial results on May 13, 2026. Analysts forecast revenue growth of 9.6%-12.4% and adjusted net profit growth of 7.3%-14.4% year-over-year. High importance is estimated due to the significant market volatility typically associated with major tech earnings releases, forecasted.
Alibaba Group will announce its unaudited financial results for the quarter and fiscal year ended March 31, 2026, scheduled. High importance is estimated as annual earnings reports for major technology firms typically drive significant price volatility exceeding 10%.
Cisco's Q3 2026 earnings release is scheduled for May 13, 2026. The company provided Q3 guidance of $15.4B-$15.6B in revenue and $1.02-$1.04 non-GAAP EPS expected.
Intel's Annual Stockholders' Meeting on May 13, 2026; low importance justified by expected <1% impact from routine proceedings, scheduled.
Q1 2026 earnings release is scheduled.
A hearing by the Shanghai Stock Exchange M&A review committee on May 11, 2026, to review the company's acquisition of a 49% stake in SMIC North, with a 1-5% price impact estimated as regulatory approval is a key step, scheduled.
Gilead is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, and will host a webcast to discuss the results and provide a business update, which is scheduled. High importance is estimated due to typical earnings volatility.
AMD is scheduled to report its fiscal first quarter 2026 financial results after the market close on May 5, 2026. This is a future event, and its impact will depend on the reported figures and forward guidance. Importance is estimated as High due to the significant potential for price movement typical of earnings releases. scheduled
Arista Networks is scheduled to release its Q1 2026 financial results after the market close on May 5, 2026. Analysts forecast revenue of approximately $2.62 billion and EPS of $0.81; the impact is neutral pending actual results, scheduled.
Eaton is scheduled to announce its first quarter 2026 earnings results before the market opens on 2026-05-05, with analysts forecasting positive year-over-year growth; high importance is estimated due to expected price impact of over 10%, forecasted.
First-quarter 2026 financial results for the period ended March 31, 2026 are scheduled to be announced on May 5, 2026, before markets open. Market reaction to the quarterly results is estimated to be at least 5% scheduled.
Palantir is scheduled to release its Q1 2026 earnings results on May 4, 2026, after the close of U.S. markets. Options markets are pricing in a potential post-earnings stock move of over 10%, expected.
Effective May 1, 2026, the price of the optional 'God's Eye B' advanced driver-assistance system package was increased by 21% from CNY 9,900 to CNY 12,000; a price impact of ≥1% is estimated as it affects only optional software margins, scheduled.
Release of unaudited Q1 2026 results reporting a 71.2% YoY increase in total revenue to RMB 11.804 billion and a 62.1% YoY increase in net profit to RMB 373 million; high growth suggests >10% price impact, scheduled.
Apple announced record Q2 2026 financial results on April 30, 2026, with revenue of $111.2 billion and EPS of $2.01, both beating analyst expectations. The company also announced a $100 billion share buyback program and a dividend increase. High importance is estimated due to the significant earnings beat and capital return program expected.
Xiaomi conducted a share repurchase on April 30, 2026, buying back 3.42 million shares for approximately HK$100 million as part of its ongoing buyback program.
Amgen reported Q1 2026 results on April 30, 2026, with EPS beating analyst forecasts and revenue meeting expectations. This is expected to have a medium market impact (>=5%) due to strong financial performance and a guidance raise, expected.
Signed a strategic cooperation agreement with DingTalk (an Alibaba company) to upgrade its operations with artificial intelligence applications. This operational partnership is estimated to have a low market impact (≥1%).
Palo Alto Networks announced its intent to acquire Portkey, a company specializing in AI gateway technology, on 2026-04-30, with the deal expected to close in the fourth quarter of fiscal 2026 expected. Positive impact is estimated as the acquisition strengthens its AI security portfolio.
The Board of Directors declared a quarterly dividend of $0.73 per share on April 30, 2026, a 7.4% increase from the prior quarter, payable on June 11, 2026.
Announced that its SSS68 injection, a dual-target antibody for APRIL/BAFF, received IND approval from China's NMPA for three autoimmune disease indications; high importance estimated due to the significant clinical potential of the dual-target antibody in three indications, expected.
Announced on April 29, 2026, a change to its share buyback plan (worth CNY 6.5B to 13B), stating that all repurchased shares will be canceled to reduce registered capital instead of being used for employee incentives. This significant reduction in share supply is estimated to have a high price impact, scheduled.
GigaDevice reported its Q1 2026 earnings on April 29, 2026, with revenue of CNY 4.19 billion (+119.38% YoY) and net profit of CNY 1.46 billion (+522.79% YoY), expected. This substantial growth is estimated to have a price impact of over 10%.
On 2026-04-29, announced Q1 2026 results with revenue of CNY 3.695 billion (+27.7% YoY) and net profit of CNY 495 million (+226.4% YoY); the massive profit surge makes a >10% price impact expected.
The U.S. Department of Commerce ordered Applied Materials to halt shipments of advanced tools to Hua Hong on April 28-29, 2026, increasing regulatory risk; estimated to have a high impact due to significant revenue exposure to China.
Amazon reported Q1 2026 earnings, beating analyst expectations with revenue of $181.5 billion and EPS of $2.78. AWS revenue growth accelerated to 28% YoY.
Reported record Q1 2026 results on April 29, 2026, with sales of $7.62 billion and adjusted EPS of $1.06, beating analyst expectations. High importance is estimated as record earnings and strong guidance typically result in ≥10% price movement.
The U.S. FDA accepted Gilead's New Drug Application (NDA) for its once-daily single-tablet HIV treatment combination, bictegravir/lenacapavir, and granted it priority review with a PDUFA action date set for August 27, 2026, which is scheduled. High importance is estimated as this is a key pipeline milestone.
Alphabet announced Q1 2026 revenue of $109.9 billion (up 22% YoY) and EPS of $5.11 on 2026-04-29, significantly beating analyst estimates. Growth was driven by strong performance in Google Search and a 63% revenue increase in Google Cloud. A >10% price impact is estimated due to the significant earnings beat, expected.
KLA reported Q3 FY2026 revenue of $3.42 billion and non-GAAP EPS of $9.40, beating analyst estimates, with strong Q4 guidance on 2026-04-29 expected; High importance justified by typical ≥10% price impact from earnings beats in this sector.
Awarded a contract from the U.S. Army with a potential value of up to $1.13 billion for High Mobility Artillery Rocket Systems (HIMARS) M142 launchers, announced on April 29, 2026; high market impact expected due to contract scale.
Qualcomm reported Q2 fiscal 2026 non-GAAP EPS of $2.65 and revenue of $10.6 billion on April 29, 2026, beating analyst estimates, though weak Q3 guidance resulted in a price impact of over 10%.
Q1 2026 financial results release on April 29, 2026, reporting a net profit of approximately 1.59 billion RMB (up 37.4% YoY) and revenue of 17.22 billion RMB (up 5.7% YoY). Medium importance estimated due to the significant projected profit growth; expected.
Announced Q1 2026 results on 2026-04-29: revenue increased 16.23% YoY to approx. RMB 1.032 billion, and net profit attributable to shareholders increased 8.91% YoY to approx. RMB 148 million. Medium importance estimated due to solid financial growth.
On 2026-04-29, shareholders approved the plan to issue RMB-denominated shares and list on the Shanghai Stock Exchange's Sci-Tech Board (STAR Market). This expansion into mainland capital markets is estimated to have a medium market impact (≥5%) due to improved liquidity.
Meta reported Q1 2026 revenue of $56.31B (+33% YoY) and EPS of $10.44, both beating analyst expectations. However, the company also raised its full-year 2026 capital expenditure guidance to $125B-$145B to support AI investments, causing the stock to decline over 8% on April 30.
The European Commission announced preliminary findings that Meta may have violated the Digital Services Act (DSA) by not adequately preventing children under 13 from accessing its platforms. A confirmed breach could result in fines of up to 6% of the company's global revenue. This significant regulatory risk is estimated to have a medium market impact of at least 5%.
Announced an $833 million contract modification for the Evolved SEASPARROW Missile Block 2 for the U.S. and allied nations.
Directors Tian Zhoushan and Li Dakui retired from the board on 2026-04-29; Low importance justified by minimal expected market impact from board personnel changes, scheduled.
Ex-dividend date for the 2025 final cash dividend of RMB 2 per 10 shares on April 29, 2026; approved at the AGM on April 16, 2026. The dividend amount suggests a >=1% price impact scheduled.
Announced Q1 2026 product revenue exceeded RMB 3.8 billion, a year-over-year increase of over 50%, driven by strong performance of its oncology and general biomedicine portfolios. The stock rose over 4.5% on the news.
Share repurchase of 300,000 shares for approximately HK$10.99 million on April 29, 2026; low impact estimated due to the relatively small transaction size scheduled.
Reported Q1 2026 results on April 29, 2026, with revenue of CNY 131.1 billion (a 2.55% YoY increase) and net profit of CNY 12.67 billion (a 2.03% YoY increase). The modest growth is estimated to result in a low price impact, expected.
Received two clinical trial approvals from China's NMPA for its self-developed Class 1 innovative drug, HS-10522 tablets, for the treatment of uncontrolled hypertension and primary aldosteronism.
The B7-H3 targeted antibody-drug conjugate (ADC) HS-20093 was granted Breakthrough Therapy Designation by China's NMPA for the treatment of advanced castration-resistant prostate cancer.
Announced that a controlling shareholder, Jiangxi Ruide, released a pledge on 25 million shares on April 28, 2026. Neutral impact is expected as pledge releases are common administrative events.
Tencent Cloud announced that its media solutions won Product of the Year awards at the 2026 NAB Show on April 29, 2026. Low importance is assigned as industry awards generally have a limited immediate impact on stock price.
Salesforce announced Agentforce Operations on 2026-04-29, a new product for automating back-office tasks. New product launches generally have a low immediate impact on stock price of at least 1%.
Microsoft reported Q3 2026 earnings on 2026-04-29 with revenue of $82.9 billion and EPS of $4.27, beating analyst expectations. However, Q4 guidance was slightly below forecasts and the company announced a significant increase in planned 2026 capital expenditures, leading to a minor stock price decline in after-hours trading.
Released Q1 2026 earnings, reporting a 55.4% year-over-year drop in net profit to CNY 4.08 billion and an 11.8% revenue decline to CNY 150.2 billion; a price impact of ≥10% is estimated due to the severe profit contraction, expected.
Released Q1 2026 results on April 28, 2026, with revenue up 3.53% YoY to CNY 38.18 billion, but net profit attributable to owners plunged 95.53% YoY to CNY 27.83 million. The 95% profit drop is estimated to cause a price impact of over 10%.
Reported Q1 2026 earnings with net profit of CNY 193 million (up 20.1% YoY) and revenue of CNY 2.036 billion (up 16.1% YoY). High price impact is expected due to significant earnings growth.
Announced Q1 2026 results, reporting revenue of CNY 656.2 million (+24.8% YoY) and a net profit of CNY 328 million, a swing to profitability from a loss of CNY 254 million in Q1 2025; high impact expected due to significant financial turnaround.
The U.S. FDA's CDER proposed withdrawing the approval for Amgen's Tavneos on April 28, 2026, citing safety concerns and data manipulation. This is expected to have a high market impact (>=10%) due to the loss of a commercial product and regulatory risks, expected.
China's CDE proposed including IBI363, a first-in-class PD-1/IL-2α bispecific antibody, for breakthrough therapy designation for the treatment of advanced MSS/pMMR colorectal cancer. This regulatory progress is estimated to have a medium market impact (≥5%).
Ivonescimab (PD-1/VEGF bispecific antibody) received multiple Class I recommendations in the 2026 Chinese Society of Clinical Oncology (CSCO) Guideline for first-line treatment of Non-Small Cell Lung Cancer (NSCLC) on 2026-04-28. Market impact is estimated at Medium because of the drug's significant role in the first-line NSCLC market.
Reported Q1 2026 financial results with revenue of $5.53 billion (up 16% YoY) and GAAP EPS of $1.36 (up 239% YoY). Results were noted to be impacted by the Middle East conflict.
Announced the opening of its flagship U.S. Bioprocess Design Center in Plainville, Massachusetts on 2026-04-28. This expansion is estimated to have a medium impact on long-term manufacturing capabilities.
With an estimated ~1% price impact as a routine corporate action, the approval of a RMB 0.286 per share final dividend at the Annual General Meeting on 2026-04-28 and its payment on 2026-06-24 are scheduled.
Received U.S. FDA clearance and CE Mark approval for Ultreon 3.0 Software, an AI-powered coronary imaging platform, on April 28, 2026.
On April 28, 2026, AMD announced its flagship global AI event, "Advancing AI 2026," to be held on July 23, 2026, to showcase its latest AI solutions.
Received a $46.5 million contract modification from the U.S. Navy to supply nine additional T408-GE-400 engines for the CH-53K King Stallion heavy-lift helicopter program. A price impact of at least 1% is expected.
Awarded a $206.23 million contract by the U.S. Navy for the design, integration, and testing of M-Code GPS capabilities for the Joint Precision Approach and Landing System.
Reported strong Q1 2026 financial results on April 27, 2026, with revenue of CNY 12.44 billion (+28.8% YoY) and adjusted non-IFRS net profit of CNY 4.60 billion (+71.7% YoY), beating expectations and causing a significant share price increase.
CATL signed a strategic cooperation agreement with Beijing Hithium Energy Storage Technology on April 27, 2026, for a 60 GWh supply of sodium-ion batteries; the high importance reflects the record-breaking scale of the order likely causing a ≥10% price impact.
Montage Technology reported strong Q1 2026 results on April 27, 2026, with revenue rising 19.5% YoY to RMB 1.46 billion and net profit attributable to shareholders jumping 61.3% YoY to RMB 847 million, driven by AI-related demand and new product sales.
Reports emerged on April 27, 2026, that Qualcomm will be a key chip supplier for OpenAI's AI-native smartphone, causing a stock price increase of over 10%.
Announced the signing of a definitive agreement to sell its microbiology business to private equity firm Astorg for approximately $1.075 billion on 2026-04-27. This significant divestiture is estimated to have a high market impact due to the strategic shift and cash inflow.
Xiaomi held its 2026 Investor Day on April 27, 2026, outlining its strategy to focus on AI as the next major growth driver and detailing plans for EV international expansion.
Q1 2026 earnings release on 2026-04-27 reporting a 6.86% YoY revenue decrease and a 15.22% YoY net profit decrease expected. Estimated price impact is 5-10% due to the significant profit decline.
On April 27, 2026, the FDA granted Priority Review for IMAAVY (nipocalimab) for the treatment of warm autoimmune hemolytic anemia (wAIHA), a rare blood disorder.
2026-04-27: Voluntary public share buy-back offer for up to 30% of D-Shares for cancellation scheduled. Estimated price impact is 1-5% due to share count reduction.
On April 27, 2026, it was announced that Oracle partnered with Bloom Energy to power its 'Project Jupiter' AI data center in New Mexico using fuel cell technology.